Dr. James Eberwine's lab at the University of Pennsylvania studies how individual brain cells respond to alcohol, especially in the context of Alcohol Use Disorder (AUD). They are using advanced techniques to look at changes in gene activity and chromatin structure in single neurons and astrocytes after alcohol exposure. The goal is to understand the underlying biology of AUD and identify potential therapeutic targets by analyzing these cellular responses in their natural brain environment.

Dr. Elizabeth Heller's lab studies the effects of epigenetic modifications on behavior, particularly in the context of substance use disorders, such as cocaine addiction. By using innovative techniques like CRISPR for locus-specific epigenetic editing, the lab aims to understand how changes at the molecular level can influence gene expression and behavior, especially in response to stress and drug exposure. The ultimate goal is to uncover potential therapeutic targets to address addiction-related issues.

Dr. Trevor M. Penning's lab at the University of Pennsylvania focuses on the health impacts of air pollution, specifically studying nitroarenes—carcinogenic compounds found in diesel exhaust. The lab investigates how these chemicals are activated in human lung cells and their potential to cause DNA damage, which may lead to cancer. Through a mix of molecular biology techniques and cell models, the lab aims to uncover mechanisms of lung cancer initiation related to environmental exposures.

Dr. Hamideh Parhiz's lab focuses on developing innovative nanotechnology to improve drug delivery for treating acute respiratory distress syndrome (ARDS). Through the use of lipid nanoparticles that can deliver modified mRNA, the lab aims to target specific lung cells to enhance therapeutic outcomes. Their research is particularly relevant given the rising incidence of ARDS and aims to provide new treatment avenues to reduce mortality rates.

Vera Moiseenkova-Bell's lab at the University of Pennsylvania focuses on understanding the TRPV channels, particularly TRPV2 and TRPV5, which are important for various physiological processes. The research aims to uncover the molecular mechanisms that control these channels' functions, particularly in neurons and immune cells. By using advanced techniques in biochemistry and imaging, the lab seeks to determine how these channels operate at the atomic level, which could have significant implications for health and disease.

Dr. Benjamin Franklin Voight's lab focuses on understanding how different types of cells in the pancreas work together to regulate blood sugar levels and how their dysfunction can lead to diabetes. They are using advanced techniques to create a detailed map of gene regulation in pancreatic islet cells, with the goal of identifying genetic factors that contribute to diabetes. This work aims to improve patient care and enhance our understanding of diabetes progression.

Dr. Yeong Shin Yim's lab at the University of Pennsylvania focuses on how maternal immune responses during pregnancy affect brain development, specifically looking at differences between males and females. Their research investigates a specific signaling pathway (CXCR7/CXCL12) that is linked to neurodevelopmental disorders like autism and schizophrenia. By understanding these differences, the lab aims to uncover new ways to address and potentially prevent issues related to brain development that are influenced by maternal health.